Watson's Mesalazine API Production Pursuing DMF Registration in the EU and Japan

Watson is a trusted leader in the production of mesalazine active pharmaceutical ingredients or API, leveraging advanced technology and a robust regulatory framework to ensure high-quality supply for global markets. Plant under Watson is actively pursuing EU Certificate of Suitability and Drug Master File registration in Japan.